A YouTuber, also known as a YouTube personality or YouTube celebrity, is a type of internet celebrity and videographer who has gained popularity from their videos on the video-sharing website, YouTube.
CANE FOUNDATION Posts
Redefining Disability, This Organisation Helps Train Differently Abled People to Find Employment
Posted in General
National Association for the Blind (Employment & Training) or Nabet is a social enterprise that loops in corporates who in turn offer industry level training and subsequent employment to the folks falling under the differently-abled strata.
Your report (Housebuilders face backlash for lobbying against disability access, 29 November) about the Home Builders Federation trying to persuade councils to stop insisting on…
AI technology such as voice interaction, image recognition and real-time captioning is starting to break down barriers for people with sensory, physical and cognitive disabilities.…
Being on a wheelchair can be different for many reasons. In fact, wheelchair users undergo various issues on a daily basis. From inaccessibility to even…
The Odisha government has signed a MoU with ‘Sightsavers’, a global organisation working to prevent avoidable blindness, to strengthen inclusiveeducation for the blind and low…
Highlighting that access to education is now a fundamental right under Article 21A, the Supreme Court on Monday questioned the lack of specially trained teachers…
Traveling is exciting, we know you agree with us. The hectic planning, the thrilling journey and the satisfaction when you reach the destination… and then, before even exploring it, you find yourself thinking about what’s next. The next stop, next activity to do, next time you’re going back to the place you are right now!
Exactly one year ago the #YellowReykjavik workshop began
Summer solstice is a good reminder, as it translates into midnight sun in Iceland: the dream of many visually impaired people with limited night vision.
Acucela Initiates Phase 2a Study of Emixustat Hydrochloride Addressing Patients with Stargardt Disease
Posted in Technology & Research
SEATTLE (January 26, 2017) — Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide, announced today that on January 25, 2017, the first patient has enrolled in a study to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (“emixustat”) in subjects with macular atrophy secondary to Stargardt disease.